Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH
Ross Baker(Murdoch University), James S. O’Donnell(Royal College of Surgeons in Ireland), Philip Choi(Australian National University), Maha Othman(Mansoura University), Nicola Curry(National Health Service), Gillian Lowe(University Hospitals Birmingham NHS Foundation Trust), Andrew Mumford(University of Bristol), Paula James(Queen's University), Keith Gomez(Royal Free London NHS Foundation Trust), Marie Lordkipanidzé(Montreal Heart Institute), Nicola J. Mutch(University of Aberdeen), Michelle Lavin(National Centre for Pharmacoeconomics), Floor Heubel-Moenen(Maastricht University Medical Centre), Johanna Gebhart(Medical University of Vienna), Peter A. Kouides(Mary M. Gooley Hemophilia Center), Will Thomas(Cambridge University Hospitals NHS Foundation Trust), Yvonne Henskens(Maastricht University Medical Centre), Robert F. Sidonio(Emory University), Michael Nagler(University Hospital of Bern), Rezan A. Kadir, Ingrid Pabinger(Vienna General Hospital)
Cited by 51
Related Papers
Increased fetal loss in women with heritable thrombophilia
|The Lancet|1996|677
Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes
|Journal of Thrombosis and Haemostasis|2012|554
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
|The Lancet|2021|521
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
|American Journal of Hematology|2012|366